PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats. | Eur J Pharmacol;538(1-3): 195-206, 2006 May 24. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.

Edgley, Amanda J; Thalén, Pia G; Dahllöf, Björn; Lanne, Boel; Ljung, Bengt; Oakes, Nicholas D.

Affiliation

Edgley AJ; AstraZeneca R and D, Research Area CV/GI, Mölndal, Sweden. amanda.edgley@med.monash.edu.au

Eur J Pharmacol ; 538(1-3): 195-206, 2006 May 24.

Article in En | MEDLINE | ID: mdl-16674938

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Propionates / Cardiomegaly / PPAR gamma / Epoxy Compounds / Fatty Acids / Glucose Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2006 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Propionates / Cardiomegaly / PPAR gamma / Epoxy Compounds / Fatty Acids / Glucose Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2006 Document type: Article Affiliation country: